Gabapentinoids (gabapentin and pregabalin / Lyrica) — patient guide

This page covers all the medicines in the gabapentinoid family. If your medicine is gabapentin (Neurontin, Pendine, Gabaran) or pregabalin (Lyrica, Lyrica CR), this is your page.

---

Find your medicine

Generic name	Common brand names	Strengths	How often	Schedule
Gabapentin	Neurontin, Pendine, Gabaran, generics	300 / 400 / 600 / 800 mg	3 times daily	Prescription-only (not S4-controlled)
Pregabalin	Lyrica, generics	25 / 50 / 75 / 150 / 300 mg	Twice daily	Schedule 4 — prescription-only, monitored
Pregabalin CR	Lyrica CR	82.5 / 165 / 330 mg	Once daily	Schedule 4 — prescription-only, monitored

Schedule 4 means pregabalin (immediate and controlled release) is monitored by the TGA and AHPRA. In Victoria, every script is captured by SafeScript. Other states have equivalent real-time prescription monitoring with varying scope. This is a routine safety system, not a sign of wrongdoing.

Closely related families. For neuropathic pain, the alternative classes are the SNRIs (duloxetine and venlafaxine) and the tricyclic antidepressants (amitriptyline and nortriptyline). For generalised anxiety disorder, the SSRIs and SNRIs are first considered before pregabalin.

---

What it treats

Gabapentinoids are prescribed for a small number of specific conditions. Your reason may be one or more of:

• Nerve pain from diabetes (diabetic peripheral neuropathy) — burning, tingling, or numb feet that gets worse at night.
• Nerve pain after shingles (post-herpetic neuralgia).
• Other nerve-injury pain — for example after a stroke, spinal cord injury, or nerve root irritation (genuine radicular pain with imaging-confirmed nerve compression, not non-specific back pain).
• Focal (partial-onset) seizures — as an add-on to other epilepsy medicines, not on its own.
• Generalised anxiety disorder — pregabalin only. The only gabapentinoid with a TGA-approved anxiety indication in Australia.

There are also off-label uses with some published evidence — fibromyalgia, restless legs syndrome, refractory chronic cough, palliative-care itch, and menopausal hot flushes when hormone therapy is contraindicated. Off-label means “not the TGA-approved use” — the evidence base varies, and the conversation about whether it makes sense for you is one to have with your GP.

What it does NOT treat

This is the section that contradicts what many people have been told.

Gabapentinoids do not work for non-specific (mechanical) chronic low back pain. Two large Australian-led trials — Mathieson 2017 in the New England Journal of Medicine, and the PRECISE trial — both found pregabalin no better than placebo for sciatica and post-surgical radicular leg pain. The Cochrane reviews of gabapentin and pregabalin for chronic pain reach the same conclusion for non-specific back pain.

Many people are on a gabapentinoid because a previous prescriber, working with the evidence of the day, started it for back pain. That is not anyone’s fault. Guidance has shifted. If you are currently taking one for back pain, the appropriate conversation with your GP is about a planned, supervised taper — not stopping suddenly. The medicine has real side effects, so if there is no benefit, the risk-benefit balance does not justify continuing.

---

The basics

1. Take it at the same times every day. Gabapentin is 3 times daily. Pregabalin is twice daily. Pregabalin CR is once daily. Miss a dose? Take the next one — do not double up.
2. Never combine without your prescriber’s knowledge with opioid painkillers, benzodiazepines (Valium-type medicines), or alcohol. The combination is the main cause of gabapentinoid-related deaths in Australia.
3. Never stop suddenly. Always taper under medical supervision. Stopping cold can cause anxiety, insomnia, nausea, sweating, and — in people with epilepsy — breakthrough seizures.
4. Call 000 for marked drowsiness with slow breathing, blue lips, or unresponsiveness — particularly after a combined dose with another sedating medicine or alcohol.

Everything else — side effects, monitoring, the chronic-back-pain conversation, the integrative angle — is below.

---

What to expect in the first month

Week 1

• You will likely feel drowsy, dizzy, and unsteady, particularly in the first few days and after the morning dose. Do not drive. Do not operate machinery. Get up slowly. These effects affect 30–40% of people early on.
• The pain or anxiety the medicine is being used for usually has not started to settle yet. Pregabalin acts faster (days to a couple of weeks). Gabapentin is slower (weeks).
• You may notice mild swelling of the ankles or feet. Tell your GP — particularly if you have heart failure.

Week 2

• The dose may be increased on a planned schedule. Each increase usually brings a fresh wave of drowsiness and dizziness for a few days.
• Light-headedness on standing should be settling, but is still common after a dose.

Weeks 3–4

• The pain or anxiety effect typically becomes clearer.
• We meet to review whether the medicine is doing what it was started to do. If it is not, that tells us something useful — the picture is more complex, or a different lever is needed. That is the conversation we have at the review.

Sick day and missed-dose rules

• One missed dose — take the next dose at the usual time. Do not double up.
• More than one missed dose — contact your GP. Restarting at the full dose after several missed doses can produce a fresh wave of sedation; restarting at a lower dose and titrating back up over a few days is sometimes safer.
• Severe vomiting or diarrhoea where you cannot keep the medicine down — contact your GP. We will plan how to bridge until you can resume.
• Surgery or general anaesthetic — tell the anaesthetist and surgeon in advance that you are taking a gabapentinoid. Most are continued through surgery, but the anaesthetic plan changes (the medicine adds to anaesthetic sedation).
• Running out — do not let this happen with pregabalin. Order the repeat at least a week before you run out. Sudden stop can cause withdrawal and, in people with epilepsy, breakthrough seizures.

---

The combination warning — read this section

This is the single most important safety conversation about gabapentinoids in Australia today.

Combining a gabapentinoid with any of the following causes additive sedation and slowed breathing. Overdose deaths involving pregabalin in combination with opioids and benzodiazepines have been rising in Australia since 2016 (Crossin et al. MJA 2019; Cairns et al. MJA 2019).

• Opioid painkillers — codeine (Panadeine Forte), tramadol (Tramal), tapentadol (Palexia), oxycodone (Endone, OxyContin), morphine (MS Contin), buprenorphine (Norspan, Subutex), fentanyl patches (Durogesic).
• Benzodiazepines — diazepam (Valium), oxazepam (Serepax), temazepam (Normison), alprazolam (Xanax), clonazepam (Rivotril).
• Z-drugs (sleep tablets) — zolpidem (Stilnox), zopiclone (Imovane).
• Alcohol — in any meaningful amount.
• Sedating antihistamines — promethazine (Phenergan), doxylamine (Restavit), diphenhydramine.
• Sedating antidepressants — particularly mirtazapine (Avanza).
• Muscle relaxants — orphenadrine (Norflex), baclofen.

Never combine without your prescriber’s explicit knowledge. Tell every doctor, dentist, surgeon, anaesthetist, and pharmacist what you are taking. Check before buying any over-the-counter sleep aid or sedating cold-and-flu remedy.

If you live with someone, it is reasonable to tell them what marked drowsiness with slow breathing looks like — pale or blue lips, very slow or shallow breathing, hard to rouse — and that the response is to call 000 immediately.

---

Tap any section below to expand the detail.

How does it work?

Gabapentin and pregabalin bind to the alpha-2-delta subunit of voltage-gated calcium channels on nerve cells. That binding reduces the release of pain-signalling and anxiety-signalling neurotransmitters (glutamate, noradrenaline, substance P) from over-active nerves. The two drugs share this mechanism — the differences between them are in how the body absorbs and processes them, not in what they do at the receptor.

The mechanism explains the side-effect profile. The same calcium-channel system runs in the cerebellum (balance, coordination) and the cortex (alertness, cognition), so quietening it produces sedation, dizziness, ataxia, and cognitive slowing as predictable companions to the analgesic effect.

The mechanism also explains why gabapentinoids work well for nerve-injury pain (where the affected nerves are pathologically over-active) and do not work for non-specific mechanical back pain (where the pain is structural rather than driven by over-active nerve signalling).

Side effects in detail

Common (usually mild, often improve with time or dose adjustment)

• Sedation and drowsiness — 30–40% in the first 2 weeks and after every dose increase. Do not drive or operate machinery until you know how the medicine affects you. Per eTG, the highest-risk window is the first 14 days.
• Dizziness and unsteadiness (ataxia) — same frequency as sedation. Particularly important in people aged 65 and over because of the fall risk.
• Peripheral oedema — swelling of ankles, feet, or hands in 5–10%. Tell your GP, especially if you have heart failure (the fluid retention can worsen heart failure).
• Weight gain — 5–10% body weight in the first 12 weeks is common with pregabalin, less common with gabapentin. Proactive nutrition and movement from day one are more effective than reactive efforts after weight has been gained.
• Cognitive slowing and memory problems — often dose-related, often reversible on dose reduction. Tell your GP if “foggy thinking” is affecting work, study, or driving.
• Blurred vision — usually settles. Mention it if persistent.
• Dry mouth, constipation, mild nausea — usually settle.

Uncommon

• Mood changes — both lifts and dips reported. Tell your GP if mood feels different on the medicine.
• Reduced libido or sexual dysfunction — reported with both drugs.

Rare but serious — act quickly

• New or worsening thoughts of suicide or self-harm — antiepileptic-class warning issued by the FDA and the TGA. Tell your GP immediately or contact Lifeline 13 11 14. If safety is at risk right now, call 000 or go to the nearest emergency department.
• Angioedema — sudden swelling of face, lips, tongue, or throat. Stop the medicine and go to the emergency department.
• Severe skin reaction — widespread rash, blistering, peeling, or rash with fever. Stop the medicine and seek urgent medical care.
• Decompensation of heart failure — new or worsening shortness of breath at rest, marked ankle swelling, sudden weight gain over a few days. Contact your GP urgently or go to ED.
• Rhabdomyolysis — severe muscle pain with dark cola-coloured urine. Rare. ED.
• Combination overdose features — marked drowsiness with slow or shallow breathing, blue lips, hard to rouse, particularly after a dose taken with an opioid, benzodiazepine, or alcohol. Call 000.

Drugs, food, and alcohol

The combination warning is above — it is the most important interaction conversation for this class. This section covers the rest.

• Antacids containing aluminium or magnesium (Mylanta, Gaviscon) — reduce gabapentin absorption. Take gabapentin at least 2 hours after the antacid. Pregabalin absorption is not affected.
• Morphine specifically — increases gabapentin blood levels by around 40%. A smaller gabapentin dose may be appropriate when these are combined. Your prescriber will plan this.
• Orlistat (Xenical) — may reduce gabapentin absorption. Clinical relevance modest.
• ACE inhibitors — rare case reports of angioedema in combination. Tell your GP about any face, tongue, or throat swelling.
• Pioglitazone — combined risk of fluid retention and peripheral oedema.
• Other sedating medicines — see the combination warning above.

Food. No specific food restrictions. Both medicines can be taken with or without food. Taking with food may reduce the early-dose sedation peak in some people.

Alcohol. Best to avoid or strictly limit. The combination adds sedation, adds impairment, and adds respiratory-depression risk. If alcohol is part of your routine, raise it with your GP rather than working around it on your own.

Generic substitution at the pharmacy. Generic gabapentin and generic pregabalin are bioequivalent to the brand-name versions. If the pharmacist offers a generic, it is fine to take. The dose is the same.

Monitoring — what blood tests and when

Gabapentinoids do not require routine blood-test monitoring in healthy adults. The main monitoring is clinical — checking that the medicine is doing what it was started to do and that side effects are tolerable.

• Kidney function — baseline check before starting, then annually, and any time kidney function may have changed (new illness, new medicine, age over 70). Both gabapentin and pregabalin are cleared by the kidneys, so the dose is reduced in people with reduced kidney function.
• Weight — at every review while titrating. Then 3-monthly for the first year.
• Mood and suicidality screening — at every review, given the antiepileptic-class signal.
• Pain or anxiety response — at the planned 2–4 week review and then 3-monthly until stable.
• Walking, balance, and falls history — particularly in people aged 65 and over.
• For people taking pregabalin — your prescriber may run a SafeScript or equivalent real-time prescription monitoring check at any consult. This is routine.

Tell your GP if you start any new medicine (prescription, over-the-counter, or supplement), notice a change in mood, have a near-miss or a fall, or notice persistent ankle swelling.

Stopping or pausing — the taper

Never stop a gabapentinoid suddenly. The withdrawal syndrome includes anxiety, insomnia, nausea, sweating, restlessness, and — in people with epilepsy — breakthrough seizures.

A typical supervised taper:

• Short-term users (under 6 weeks) — taper over 1–2 weeks.
• Established users (months to years) — reduce the daily dose by 10–25% every 1–2 weeks. Slower for higher doses. Slower for longer duration of use. Slower in people with a history of withdrawal symptoms.
• People taking a gabapentinoid for epilepsy — the taper is mandatory and slower, and is usually coordinated with the treating neurologist.

The taper conversation typically covers: which dose drops are made when, what to expect during each drop, when to slow down or pause, what the off-medicine plan is for the original indication (pain plan, anxiety plan, seizure plan), and what the contingency plan is if withdrawal symptoms become marked.

This is a planned conversation, not an improvised one. Book a dedicated review with your GP before changing the dose.

Older adults — the fall conversation

Gabapentinoids cause a measurable rise in falls in people aged 65 and over. The mechanism is the predictable sedation + dizziness + ataxia of the class, layered onto an age group with already-reduced balance reserve.

The defensible approach in people aged 65 and over:

• Lower starting dose. Often half the standard starting dose.
• Slower titration. Often weeks rather than days between dose increases.
• Lower target maintenance dose. Often two-thirds of the standard adult dose.
• Home-hazard review. Loose rugs, poor lighting at night, bathroom rails, clear paths between bed and bathroom.
• Walking-aid review. If a stick or frame would help, this is the moment.
• Vitamin D check — supports bone strength if a fall does happen.
• Bone-density consideration — particularly in women over 65 and men over 70 with other risk factors.

If you have had a near-miss or a fall on the medicine, that is a reason to review urgently rather than wait for the next routine appointment.

Pregnancy and breastfeeding

Gabapentinoids are AU pregnancy category C — there is a documented antiepileptic-class fetal risk. The first trimester is the most sensitive window.

• Planning a pregnancy — tell your GP before trying to conceive. For some indications (chronic pain, anxiety) we plan a taper and transition to a pregnancy-safer alternative. For others (poorly controlled epilepsy in particular) the risks of uncontrolled disease may outweigh the risks of the medicine, and the decision is made together with your obstetric team and (where relevant) your neurologist.
• Already on the medicine and just found out you are pregnant — contact your GP as soon as possible. Do not stop suddenly. The plan is made together with your team.
• Folate 5 mg/day — recommended pre-conception and through the first trimester for anyone who may need to continue an antiepileptic-class medicine.
• Breastfeeding — both gabapentin and pregabalin transfer into breast milk in small amounts. The decision to continue or switch is made case by case. Many women breastfeed safely while on these medicines under monitoring.

If a younger family member or housemate is curious about your tablets

This is included because pregabalin in particular has a misuse signal in Australia, and curious-housemate-access is a real route to harm.

• Store the medicine out of easy reach. Not on the kitchen counter, not in a handbag left on a hall table.
• Do not share your script. Pregabalin handed to a friend “for their pain” can sedate, cause respiratory depression, and — particularly in combination with alcohol or another sedating drug — kill.
• If a tablet goes missing, tell your GP. It is a brief, non-judgemental conversation and is the right thing to do.
• If you have a young child in the home or visiting, a child-resistant container is worth it.

Cost

Both gabapentin and pregabalin are listed on the PBS for their on-label indications. From 1 January 2026, the PBS co-payment is:

• General patient — up to $25.00 per script.
• Concession card holder — up to $7.70 per script.

Authority requirements:

• Gabapentin — PBS Authority required for refractory neuropathic pain and as add-on for focal seizures. Your prescriber will arrange the Authority.
• Pregabalin — PBS Streamlined Authority code required for neuropathic pain. The pregabalin GAD indication is not currently PBS-listed — if pregabalin is prescribed for anxiety, the script may be private rather than PBS.
• Pregabalin CR (Lyrica CR) — confirm with your pharmacist whether the controlled-release formulation is PBS-listed at the time you fill the script. If not, it is available privately at a higher cost.

Generic versions cost the same as brand-name versions at PBS pricing and work the same. Confirm with your pharmacist — they can show you the exact price for your script and tell you the cheapest option.

---

The integrative view

This is the part where the conversation widens. The gabapentinoid is one lever. There are others. The strongest pain plans use several together — medicine, movement, sleep, nutrition, and mind-body work — because chronic pain is rarely a single-system problem.

Two principles. First: where there is genuine nerve-injury pain or genuine generalised anxiety, gabapentinoids work and they are reasonable to use. Second: medicines are rarely the whole answer in chronic pain, and the most durable improvements come from changes the medicine cannot make on its own.

Strong evidence — these reliably help

• Sleep optimisation. Poor sleep amplifies the perception of neuropathic pain. Consistent sleep timing, dark and cool bedroom, screen taper before bed, and treatment of obstructive sleep apnoea if snoring + observed pauses + daytime tiredness suggest it. Pain-score reductions from sleep work are real and often surprise people in their magnitude.
• Graded movement. Even in chronic pain — particularly in chronic pain — graded exercise reduces pain scores, reduces medication need, and improves function. The graded part matters: start low, build slow, sustain.
• Cognitive behavioural therapy for chronic pain (CBT-CP), acceptance and commitment therapy (ACT), and mindfulness-based stress reduction (MBSR). These have the strongest evidence base of any non-pharmacological intervention in chronic pain (NICE NG193). The mechanism is not “thinking your way out of pain” — it is reshaping the relationship between pain signal and suffering, which is a different neural process.
• Avoiding alcohol. Additive sedation. Additive respiratory-depression risk. Additive risk of dependence on either substance.

Moderate evidence — likely helpful

• Alpha-lipoic acid 600 mg/day — modest evidence in diabetic peripheral neuropathy. Specialty-society guidance supports it as an adjunct. Not a replacement for the gabapentinoid where the gabapentinoid is working.
• Acetyl-L-carnitine 1–3 g/day — modest evidence in diabetic peripheral neuropathy. Same caveat — adjunct, not replacement.
• B-complex, particularly B12. Long-term metformin use is associated with B12 deficiency, and B12 deficiency can mimic or worsen peripheral neuropathy. A B12 level is reasonable in anyone with diabetic peripheral neuropathy and metformin exposure.
• Omega-3 (EPA + DHA), 1–3 g/day. Modest evidence in neuropathic pain. Stronger evidence for general cardiovascular and inflammatory benefit.
• Vagal-tone work. Slow nasal breathing at around 6 breaths per minute, cold-water face immersion, humming. Particularly relevant where pregabalin is being used for generalised anxiety — these work alongside the medicine, not against it.

Limited or emerging evidence

• Magnesium. Adequacy supports nerve function generally; evidence specifically in gabapentinoid-treated patients is limited. Food-first.
• Vitamin D. Supplement only if a blood test shows deficiency.
• Topical capsaicin and topical lidocaine. Useful for localised neuropathic pain (post-herpetic neuralgia, focal diabetic neuropathy patches). Worth discussing with your GP as an adjunct.
• Acupuncture. Mixed evidence in chronic pain generally; some people respond well, many do not. Reasonable to trial for 6 sessions and decide based on personal response.

Specific to being on a gabapentinoid

• Weight management from day one. Mediterranean-pattern eating, protein adequacy, fibre target around 25–30 g/day, and regular movement from the day the medicine is started — not after weight has been gained. The 5–10% weight gain is much harder to reverse than to prevent.
• Alcohol. Avoid or strictly limit. The additive risk is real.
• Driving and machinery. Do not drive until you know how the medicine affects you. After every dose increase, the question reopens.
• B12 if on metformin. Check the level.
• Vitamin D if you fall in the deficient range. Supplement.

Earning a lower dose, or coming off

For non-cancer chronic pain particularly, the goal is rarely lifetime gabapentinoid therapy. The realistic goal is: medicine + active plan → pain-score reduction → pain-plan strengthens → medicine dose comes down → in many cases the medicine comes off entirely.

This is a planned process, not a “see how it goes” process. The conversation about reducing the dose, and what the off-medicine pain plan looks like, is a planned appointment with your GP — typically once the pain has been stable on the current dose for 3–6 months.

If you are on a gabapentinoid for epilepsy, that is different — the medicine is usually continued long-term, and the conversation is about optimisation rather than withdrawal.

---

Track these between now and your next visit

• Pain or anxiety scores — a simple 0–10 rating, same time each day, takes 5 seconds.
• Sleep — quality, hours, any consistent disruption.
• Drowsiness or unsteadiness — when in the day, how marked, any near-misses or falls.
• Mood — note any change, particularly any new low or any thought of self-harm. If safety is at risk, contact Lifeline 13 11 14 or call 000.
• Weight — once a week, same time of day, same clothing.
• Anything new you have started — over-the-counter medicines, supplements, alcohol changes, other prescribers’ prescriptions.

Bring the list to your review appointment.

---

This is general information, not personal medical advice. Every patient is different. Decisions about your medicines — which one, what dose, when to stop, what to combine with — are made with the doctor who prescribed them. If anything on this page appears to contradict advice from your treating doctor, follow your doctor; they have context about your situation that this page cannot.

Reading this page does not establish a doctor-patient relationship with Dr Hoebing Lo. If you are not a current patient, please discuss your medicines with your own GP, specialist, or pharmacist.

About the integrative content. The lifestyle, dietary, and complementary recommendations on this page summarise current published research. Effect sizes are approximations from clinical studies — your individual response will vary, and real-world results are commonly smaller than trial results because day-to-day life differs from study conditions. Supplements and herbal products are not interchangeable with prescribed medication and can interact with it. Talk to your doctor and pharmacist before starting any new supplement, herbal product, or significant change in diet.

Currency. This page reflects clinical practice as of the last-reviewed date. Medicine evolves; specific details may date between reviews. Pricing shown is indicative; confirm with your pharmacist.

No commercial relationships. Dr Hoebing Lo has no financial or commercial relationship with the manufacturer of any medicine, brand, or supplement mentioned on this page.

Emergencies. If you have sudden swelling of face, lips, tongue, or throat; difficulty breathing; marked drowsiness with slow or shallow breathing; chest pain; thoughts of suicide or self-harm; or severe dizziness or fainting — call 000 or go to your nearest emergency department. For mental-health crisis support, Lifeline 13 11 14 is available 24 hours.